Vilhelm Wessman

Vilhelm Róbert Wessman was the founder of Alvogen, Inc. (founded 2009) where the title held was Chairman & Chief Executive Officer.
Mr. Wessman is the founder of Aztiq Pharma Partners ehf (founded 2019) holding the title of Co-Chairman.
Mr. Wessman was the founder of Alvogen Iceland ehf (founded 2010) where the title held was Chief Executive Officer.
Mr. Wessman is the founder of Alvotech hf (founded 2012) holding the title of Executive Chairman.
Mr. Wessman is the founder of Alvogen Emerging Markets Holdings Ltd. (founded 2009) where the title held is Chairman & Chief Executive Officer.
Mr. Wessman is the founder of Alvotech (founded 2013) holding the title of Executive Chairman.
Current jobs include Chairman & Chief Executive Officer at Alvogen Lux Holdings SARL; Chairman at Lotus Pharmaceutical Co., Ltd. since 2018; Chairman at Adalvo Ltd.; Director at Fuji Pharma Co., Ltd. since 2018; Director at Iceland Chamber of Commerce since 2007; Director at Norwich Clinical Services Pvt Ltd.; Director at Kunwha Pharmaceutical Co., Ltd.; Director at Alvogen Ipco SARL; Director at Alvogen Aztiq AB since 2014; Director at Aztiq Pharma Partners SARL since 2019.
Former jobs included Chief Executive Officer at Actavis, Inc. from 1999 to 2008; President & Chief Executive Officer at Delta ehf; Chief Executive Officer at Samskip GmbH; Chairman & Chief Executive Officer at Alvogen Iceland ehf; Chairman & Chief Executive Officer at Alvogen Pharma US, Inc.; Chairman at Alvotech Holdings SA; Director at Actavis Group ehf; Director at Alvogen Korea Co., Ltd.; Lecturer at the University of Iceland.
Education includes undergraduate degree from the University of Iceland.